Mankind Pharma is in talks with PE companies to acquire Bharat Serums and Vaccines. Owner Advent International aims to sell BSV for over $2 billion, with the final transaction expected to be ...

Brothers Ramesh (left) and Rajeev Juneja at Mankind Pharma's headquarters in Delhi. Mankind Pharma—owned by Indian billionaire brothers Ramesh and Rajeev Juneja— has agreed to buy Bharat ...

As I step into Rajeev Juneja’s office at Mankind Pharma’s Delhi headquarters, the wall in front of me immediately commands attention. It features a collection of iconic quotes and striking ...

As Mankind Pharma gears up to go public, its 544-page draft IPO paper throws up an interesting name, Dabur India. One wonders why would a century-old fast-moving consumer goods (FMCG) major be ...

Mankind Pharma, a pharma/ consumer healthcare (HC) player ranked fourth by sales in the IPM (Indian Pharmaceutical Market), is IPO-bound (April 25-27). The offer is entirely an OFS of ₹4,326 ...

Motilal Oswal is bullish on Mankind Pharma recommended buy rating on the stock with a target price of Rs 2910 in its research report dated May 22, 2025. Mankind Pharma Consolidated March 2025 Net ...